Efficacy and safety of pembrolizumab in Chinese patients with recurrent/unresectable/metastatic head and neck squamous cell carcinoma.

被引：0
|
作者：
Li, Jieying [1 ]
Song, Kai [1 ]
Feng, Yuanyong [1 ]
Shang, Wei [1 ]
机构：
[1] Univ Affiliat Hosp Qingda, Affiliated Hosp Qingdao, Qingdao, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18001
引用
收藏
页码：E18001 / E18001
页数：1
相关论文
共 50 条
  • [21] Safety/efficacy of a phase I/II study of SNS-301 added to pembrolizumab in patients with ASPH plus locally advanced unresectable or metastatic/recurrent squamous cell carcinoma of the head and neck (SCCHN).
    Smith, William
    Celebi, John
    Pierce, Robert
    Drumheller, Alice
    Csiki, Ildiko
    Algazi, Alain Patrick
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [22] Dose expansion results of the bifunctional EGFR/TGFβ inhibitor BCA101 with pembrolizumab in patients with recurrent, metastatic head and neck squamous cell carcinoma.
    Hanna, Glenn J.
    Kaczmar, John M.
    Zandberg, Dan Paul
    Wong, Deborah J. L.
    Yilmaz, Emrullah
    Sherman, Eric Jeffrey
    Hernando-Calvo, Alberto
    Sacco, Assuntina G.
    Chung, Christine H.
    Bohr, David
    Reiners, Ralf
    Salazar, Rachel
    Gharakhani, Elham
    Bilic, Sanela
    Muzaffar, Jameel
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [23] Therapy of recurrent or metastatic head and neck squamous cell carcinoma. Highlights of the ASCO Meeting 2014
    Zeller, N.
    Busch, C-J.
    Schafhausen, P.
    Knecht, R.
    Moeckelmann, N.
    HNO, 2014, 62 (11) : 787 - 792
  • [24] Efficacy and safety of apatinib in patients with recurrent or metastatic head and neck squamous cell carcinoma: a retrospective multi-center study
    Zijing Liu
    Zhuangzhuang Zheng
    Lihua Dong
    Xiao Guo
    Xiaojing Jia
    Jianfeng Wang
    Lingbin Meng
    Xiangyan Cui
    Xin Jiang
    Scientific Reports, 12
  • [25] Efficacy and safety of apatinib in patients with recurrent or metastatic head and neck squamous cell carcinoma: a retrospective multi-center study
    Liu, Zijing
    Zheng, Zhuangzhuang
    Dong, Lihua
    Guo, Xiao
    Jia, Xiaojing
    Wang, Jianfeng
    Meng, Lingbin
    Cui, Xiangyan
    Jiang, Xin
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [26] Nivolumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab Use
    Ferris, Robert L.
    Licitra, Lisa
    Fayette, Jerome
    Even, Caroline
    Blumenschein, George, Jr.
    Harrington, Kevin J.
    Guigay, Joel
    Vokes, Everett E.
    Saba, Nabil F.
    Haddad, Robert
    Ramkumar, Shanmugasundaram
    Russell, Jeffery
    Brossart, Peter
    Tahara, Makoto
    Colevas, A. Dimitrios
    Concha-Benavente, Fernando
    Lynch, Mark
    Li, Li
    Gillison, Maura L.
    CLINICAL CANCER RESEARCH, 2019, 25 (17) : 5221 - 5230
  • [27] Efficacy and Safety of Iodine-125 Brachytherapy in the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
    Wu, Chunrong
    Li, Bo
    Sun, Guiyin
    Peng, Chunfang
    Xiang, Debing
    ONCOTARGETS AND THERAPY, 2020, 13 : 9657 - 9666
  • [28] A phase II trial of pembrolizumab and cabozantinib in patients (pts) with recurrent metastatic head and neck squamous cell carcinoma (RMHNSCC).
    Saba, Nabil F.
    Ekpenyong, Asari
    McCook-Veal, Ashley
    Patel, Mihir
    Schmitt, Nicole Cherie
    Stokes, William A.
    Bates, James Edward
    Rudra, Soumon
    Abousaud, Marin Ibrahim
    Muzaffar, Jameel
    Kirtane, Kedar
    Teng, Yong
    Steuer, Conor Ernst
    Shin, Dong Moon
    Liu, Yuan
    Chung, Christine H.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [29] The effect of opioids on the efficacy of immunotherapy in recurrent/ metastatic squamous cell carcinoma of the head and neck
    Scheff, Nicole N.
    Nilsen, Marci L.
    Li, Jinhong
    Harris, Alexandria L.
    Acharya, Rajesh
    Swartz, Andrew
    Hsieh, Ronan W.
    Anderson, Jennifer L.
    Ferris, Robert L.
    V. Menk, Ashley
    Delgoffe, Greg M.
    Zandberg, Dan P.
    ORAL ONCOLOGY, 2023, 140
  • [30] Paclitaxel and cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma
    Adamo, V
    Ferraro, G
    Pergolizzi, S
    Sergi, C
    Laudani, A
    Settineri, N
    Alafaci, E
    Scimone, A
    Spano, F
    Spitaleri, G
    ORAL ONCOLOGY, 2004, 40 (05) : 525 - 531
12345